TOUCHCELL
Telehaptic Micromanipulator System
| Coordinatore | UNIVERSITY COLLEGE LONDON
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 168˙218 € |
| EC contributo | 149˙995 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | ERC-2012-PoC |
| Funding Scheme | CSA-SA(POC) |
| Anno di inizio | 2014 |
| Periodo (anno-mese-giorno) | 2014-01-01 - 2015-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
YANTRIC INC FOR PROFIT CORPORATION
Organization address
address: CROSS STREET 31 contact info |
US (WEST NEWTON MA) | beneficiary | 52˙804.50 |
| 2 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | hostInstitution | 97˙190.50 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The ability to handle individual cells and operate on them safely and efficiently is increasingly important in a number of fields such as biotechnology, pharmacology, agriculture, oncology, genetics, neuroscience and embryology. In our ERC-AdG project, we have already demonstrated a micromanipulation system that enables a user to touch, manipulate and assemble individual algae cells and polystyrene beads, almost as naturally as we handle objects in our macroscopic world. To demonstrate the impact of this capability, we start by developing TouchCell, an indispensable tool that targets known challenges within the in-vitro fertilisation (IVF) domain. With TouchCell, users are able to uniquely touch and feel cellular forces through tools in real-time, helping them to perform tasks such as micro-injections, biopsies and tool-to-cell interactions with greater control, ease and efficiency. Further, by using haptic technology and robotic techniques, automation of certain cell manipulation tasks is possible. TouchCell will also be able to capture the mechanical properties of cells at a micron scale thought to be of value. By working closely with IVF experts at UCL, we will establish the technical and economic benefits of using TouchCell within the clinic. Expected outcomes also include a number of commercial milestones such as demonstrations of the TouchCell system to potential customers and manufacturers in addition to new IP. Altogether, these activities will provide an entry point in the broader market of micromanipulation for future commercialisation opportunities.'